ADD A CATEGORY
FEB 25, 2013 - Benzinga
A Must Read - Share
In a report published Sunday, Piper Jaffray reiterated an Overweight rating for Amgen (NASDAQ: AMGN) and raised its price target from $104 to $107.
Hey you have no friends!!! Get to work and start inviting friends to help build your Comunitee. Click Here to invite friends.
© 2011 Comunitee, Inc.